MINNEAPOLIS, Nov. 30 /PRNewswire/ -- Nonin Medical, Inc., a leading innovator of physiological monitoring solutions and the inventor of fingertip pulse oximetry, was awarded Frost and Sullivan's 2009 North American Product Line Strategy Award in Remote Patient Monitoring. Recognized for providing secure, accurate remote physiological monitoring, Nonin Medical was acknowledged for its leadership as a premier provider of telemedicine monitoring equipment.
The Product Line Strategy award is chosen by Frost and Sullivan's analyst team, which conducts interviews with suppliers, end-users and industry experts to determine the product that best addresses market needs and dynamics. "As the world of telemedicine continues to evolve, there is a need for monitoring companies to develop new monitoring devices in order to perform that critical first step of any telemedicine system, vital sign or data acquisition," observed industry analyst Zachary Bujnoch. "Nonin Medical has already established itself as a true thought leader in this monitoring specific side of remote medicine."
With rising healthcare costs driving care into the home, Nonin's vision of remote monitoring has focused on how to provide cost-effective, accurate physiological data exchange with no proprietary boundaries. Nonin's choice to promote secure information exchange and interoperability has enabled a simpler delivery of health care for telemedicine systems, healthcare systems, systems integrator partners and patients worldwide. Nonin's remote monitoring solutions have provided patients with better information about their health status and allowed clinicians to monitor vital signs with greater ease across the globe.
Together with other industry leaders within the Continua Health Alliance, Nonin is contributing to the advancement of interoperable devices and open standards development to promote the Personal Health ecosystem. "Through these partnerships, our goal for interoperable remote monitoring is to simplify the delivery of health care with an end result that will ultimately benefit both the patient and provider with reduced costs, added security, improved efficiencies and increased compliance rates," said Jayant Parthasarathy, Ph.D., eHealth Business Manager at Nonin Medical and Chairperson of the Continua Health Alliance Technical Working Group.
Known for its accurate PureSAT® pulse oximetry technology, innovative design, low power consumption and unmatched durability, Nonin's vital sign monitoring solutions have become the gold standard for assessment of a wide range of chronic disease conditions, such as COPD, CHF and asthma.
About Nonin Medical, Inc. - www.nonin.com
Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing in the design and manufacturing of noninvasive physiological monitoring solutions. Nonin distributes its products to health professionals in more than 125 countries and has over 100+ OEM partners worldwide. With over 20 years of industry-leading capabilities in signal processing and sensor design expertise, Nonin's innovative noninvasive physiological technologies enable clinicians to accurately monitor a patient's true condition in the most challenging environments.
About Frost & Sullivan - www.frost.com
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
SOURCE Nonin Medical, Inc.
|SOURCE Nonin Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved